/MDBIF
MDBIF Stock - TrivarX Limited
Healthcare|Medical - Healthcare Information ServicesOTC
$0.02+0.00%
+$0.00 (+0.00%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.33
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDBIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.01
RISK/REWARD1:0.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$0.02
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.13M | $888,829 | $960,451 | $1.01M | $1.26M |
| Gross Profit | $1.13M | $-93,133 | $-1,154,200 | $1.00M | $1.09M |
| Gross Margin | 100.0% | -10.5% | -120.2% | 99.9% | 86.5% |
| Operating Income | $128,253 | $-2,116,960 | $18,060 | $-504,170 | $27,227 |
| Net Income | $-943,231 | $-1,237,093 | $-3,070,546 | $-12,715,807 | $-1,486,602 |
| Net Margin | -83.5% | -139.2% | -319.7% | -1264.7% | -117.7% |
| EPS | $-0.00 | $-0.00 | $-0.02 | $-0.12 | $-0.02 |
Company Overview
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MDBIFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q3 24
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q3 2025 | Aug 4, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 30, 2025 | — | — | — | — |
Q3 2024 | Aug 28, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 28, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.08 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.02 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.15 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.30 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.78 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.52 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.74 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.32 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.70 | — | — |
Latest News
Loading news...
Frequently Asked Questions about MDBIF
What is MDBIF's current stock price?
TrivarX Limited (MDBIF) is currently trading at $0.02 per share. The stock has moved +0.00% today.
What is the analyst price target for MDBIF?
No analyst price targets are currently available for this stock.
What sector is TrivarX Limited in?
TrivarX Limited operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.
What is MDBIF's market cap?
TrivarX Limited has a market capitalization of $0.01 billion, making it a small-cap company.
Does MDBIF pay dividends?
No, TrivarX Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAIMLF
AI/ML Innovations Inc.
$0.03
Mkt Cap: $0.0B
CMHSF
Comprehensive Healthcare Systems, Inc.
$0.35
Mkt Cap: $0.0B
FPCG
First Physicians Capital Group, Inc.
$1025.00
Mkt Cap: $0.0B
MMJJF
Underwood Capital Limited
$0.04
Mkt Cap: $0.0B
OXBOF
Oxford BioDynamics Plc
$0.00
Mkt Cap: $0.0B
PAXH
PreAxia Health Care Payment Systems Inc.
$0.22
Mkt Cap: $0.0B
SPLTF
SpotLite360 IOT Solutions, Inc.
$0.08
Mkt Cap: $0.0B
TRUFF
Red Light Holland Corp.
$0.02
Mkt Cap: $0.0B
UDOCF
Unidoc Health Corp.
$0.13
Mkt Cap: $0.0B
VYND
Vynleads, Inc.
$0.32
Mkt Cap: $0.0B
Explore stocks similar to MDBIF for comparison